Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Incyte Corporation
With
Novartis Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with neoplastic disease refractory to currently available therapies or for which no effective treatment is available
Subjects with life expectancy of 12 weeks or longer.
Subjects with Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2.
You may not be if
Subjects who received any anti-cancer medications in the 21 days prior to receiving their first dose of study medication or 6 weeks for mitomycin-C or nitrosoureas.
Subjects with history of brain metastases or spinal cord compression.
Subjects who have undergone a bone marrow or solid organ transplant.
Subjects who have had major surgery within 4 weeks prior to study entry or had minor surgical procedure within 7 days prior to initiating treatment.
Subjects with clinically significant non-healing or healing wounds or subjects with lung tumor lesions with increased likelihood of bleeding
Subjects with a history of any gastrointestinal condition
